Your browser doesn't support javascript.
loading
Percutaneous Coronary Intervention in Men, Women, and Minorities With a Previous Coronary Artery Bypass Graft Surgery (from the Pooled PLATINUM Diversity and PROMUS Element Plus Registries).
Beerkens, Frans J; Cao, Davide; Batchelor, Wayne; Sartori, Samantha; Kandzari, David E; Davis, Scott; Tamis, Luis; Wang, John C; Othman, Islam; Vogel, Birgit; Spirito, Alessandro; Subramaniam, Varsha; Gigliotti, Osvaldo S; Haghighat, Amir; Feng, Yihan; Singh, Sarabjeet; Lopez, Mario; Giugliano, Gregory; Horwitz, Phillip A; Dangas, George; Mehran, Roxana.
Afiliação
  • Beerkens FJ; The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, New York.
  • Cao D; The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, New York; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, MI, Italy.
  • Batchelor W; Inova Heart and Vascular Institute, Inova Health System, Fairfax, Virginia.
  • Sartori S; The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, New York.
  • Kandzari DE; Department of Interventional Cardiology, Piedmont Heart Institute, Atlanta, Georgia.
  • Davis S; Interventional Cardiology, Baptist Hospital, Little Rock, Arkansas.
  • Tamis L; Research Physicians Network Alliance, Hollywood, Florida.
  • Wang JC; Department of Interventional Cardiology, Medstar Union Memorial Hospital, Baltimore, Maryland.
  • Othman I; Division of Cardiology, Department of Medicine, Duke University Health System, Durham, North Carolina.
  • Vogel B; The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, New York.
  • Spirito A; The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, New York.
  • Subramaniam V; The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, New York.
  • Gigliotti OS; Ascension Texas Cardiovascular, Austin, Texas.
  • Haghighat A; Cardiovascular Institute of Northwest Florida, Panama City, Florida.
  • Feng Y; The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, New York.
  • Singh S; Central Cardiology Medical Clinic, Bakersfield, California.
  • Lopez M; Charlotte Heart and Vascular Institute, Port Charlotte, Florida.
  • Giugliano G; Interventional Cardiology, Baystate Medical Center, Springfield, Massachusetts.
  • Horwitz PA; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Indiana.
  • Dangas G; The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, New York.
  • Mehran R; The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: Roxana.mehran@mountsinai.org.
Am J Cardiol ; 200: 204-211, 2023 08 01.
Article em En | MEDLINE | ID: mdl-37354778
ABSTRACT
There is limited data on new-generation stent outcomes in patients with previous coronary artery bypass graft (CABG) and the associated risk of gender and race/ethnicity is unclear. We investigated 1-year outcomes after platinum chromium everolimus-eluting stent implantation in a diverse population of men, women, and minorities with previous CABG pooled from the PLATINUM Diversity (NCT02240810) and PROMUS Element Plus (NCT01589978) registries. Our primary outcome was major adverse cardiac events (MACE), a composite of all-cause death, myocardial infarction (MI), and target vessel revascularization (TVR) at 1-year post percutaneous coronary intervention (PCI). Secondary end points included all-cause death, MI, TVR, target vessel failure, and stent thrombosis. A total of 4,175 patients were included in the analysis, including 1,858 women (44.5%), 1,057 minorities (25.3%), and 662 (15.9%) with previous CABG. Patients with previous CABG were older, included more men and White patients, and had more co-morbidities compared with patients without previous CABG. At 1 year, patients with previous CABG had a higher risk of MACE (12.6% vs 7.5%, hazard ratio 1.70, 95% confidence interval 1.32 to 2.19, p <0.001) and end points, including death/MI, TVR, and target vessel failure. After multivariate adjustment, no differences were observed in MACE (adjusted hazard ratio 1.11, 95% confidence interval 0.82 to 1.49, p = 0.506) or any secondary end points. No interaction was observed between previous CABG and gender or minority status. In conclusion, in a contemporary PCI population, patients with previous CABG remain at high risk for PCI because of their elevated risk profile. Previous CABG status was however not independently associated with worse outcomes after adjustment, nor was any interaction observed with gender or race/ethnicity.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Stents Farmacológicos / Intervenção Coronária Percutânea / Infarto do Miocárdio Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Am J Cardiol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Stents Farmacológicos / Intervenção Coronária Percutânea / Infarto do Miocárdio Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Am J Cardiol Ano de publicação: 2023 Tipo de documento: Article